Revvity, Inc.
RVTY
$1.51 (1.60%)
1D
1W
3M
1Y
5Y
ALL
Revvity, Inc. is a provider of health science solutions, technologies, and services, which delivers workflows from discovery to development, and diagnosis to cure. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The Life Sciences Segment applications include MicroBeta, The MuviCyte live-cell imaging system, The Signals Image Artist, The VICTOR Nivo multimode plate reader benchtop system, The EnSight multimode plate reader benchtop system, BioLegend LEGENDplex bead-based reagents, and The Quantum GX2 system. Its Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. It offers instruments, reagents, assay platforms and software to hospitals, and medical labs. It is focused on reproductive health, immunodiagnostics, and emerging market diagnostics.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Zacks Investment Research • 4 days ago • RVTY
RVTY Expands Endocrine Diagnostics With FDA-Cleared Testosterone Assay
Seeking Alpha • 5 days ago • RVTY
Revvity, Inc. (RVTY) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Zacks Investment Research • 13 days ago • RVTY
RVTY Q1 Earnings Beat Estimates on Organic Growth & Strong Execution
Seeking Alpha • 13 days ago • RVTY
Revvity, Inc. (RVTY) Q1 2026 Earnings Call Transcript
Zacks Investment Research • 13 days ago • RVTY
Compared to Estimates, Revvity (RVTY) Q1 Earnings: A Look at Key Metrics
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.